InvestorsObserver
×
News Home

Pasithea Therapeutics Corp (KTTA) is down 1.79% Monday In Premarket Trading

Monday, December 06, 2021 08:59 AM | InvestorsObserver Analysts

Mentioned in this article

Pasithea Therapeutics Corp (KTTA) is down 1.79% Monday In Premarket Trading

Pasithea Therapeutics Corp (KTTA) has fallen Monday morning, with the stock falling -1.79% in pre-market trading to 2.75. KTTA's short-term technical score of 19 indicates that the stock has traded less bullishly over the last month than 81% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, Pasithea Therapeutics Corp ranks higher than 39% of stocks. Pasithea Therapeutics Corp has risen 10.67% over the past month, closing at $2.52 on November 8. During this period of time, the stock fell as low as $2.21 and as high as $8.50.

Overall Score - 6
KTTA has an Overall Score of 6. Find out what this means to you and get the rest of the rankings on KTTA!
Pasithea Therapeutics Corp has a Long-Term Technical rank of 0. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 100% of the market scoring higher. In the Biotechnology industry which is number 140 by this metric, KTTA ranks better than 0% of stocks.

Important Dates for Investors in KTTA:

-We do not have a set earnings date for Pasithea Therapeutics Corp at this time. -We do not have a set dividend date for Pasithea Therapeutics Corp at this time. Click Here To Get The Full Report on Pasithea Therapeutics Corp (KTTA)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App